April 24, 2012 —ActiViews Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its flagship product, CT-Guide Needle Guidance System, for liver interventions.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now